ibuleve.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Sitemap: | ||
Meta Tags
| Title | Ibuleve: Fast & Effective Pain Relief With The Power Of |
| Description | Ibuleve harnesses the painkilling anti-inflammatory power of Ibuleve Gel can work as quickly and effectively as 400mg ibuprofen tablets for treating painful injuries such as back pain, sprains and |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 92.52.69.162 |
| Location | United Kingdom |
Related Websites
| Site | Rank |
More to Explore
ibuleve.com Valuation
|
US$2,220,956
Last updated: 2023-05-17 02:21:03
ibuleve.com has Semrush global rank of 4,765,652. ibuleve.com has an estimated worth of US$ 2,220,956, based on its estimated Ads revenue. ibuleve.com receives approximately 256,265 unique visitors each day. Its web server is located in United Kingdom, with IP address 92.52.69.162. According to SiteAdvisor, ibuleve.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,220,956 |
| Daily Ads Revenue | US$2,051 |
| Monthly Ads Revenue | US$61,504 |
| Yearly Ads Revenue | US$738,041 |
| Daily Unique Visitors | 17,085 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| ibuleve.com. | A | 86400 | IP: 92.52.69.162 |
| ibuleve.com. | NS | 86400 | NS Record: ns1.netnames.net. |
| ibuleve.com. | NS | 86400 | NS Record: ns2.netnames.net. |
| ibuleve.com. | NS | 86400 | NS Record: ns5.netnames.net. |
| ibuleve.com. | NS | 86400 | NS Record: ns6.netnames.net. |
| ibuleve.com. | MX | 86400 | MX Record: 10 eu-smtp-inbound-2.mimecast.com. |
| ibuleve.com. | MX | 86400 | MX Record: 10 eu-smtp-inbound-1.mimecast.com. |
| ibuleve.com. | TXT | 86400 | TXT Record: MS=ms79729897 |
| ibuleve.com. | TXT | 600 | TXT Record: 0ed1fe018a42a24406cd9d4e9f807605fbea891965 |
HtmlToTextCheckTime:2023-05-17 02:21:03
| We need your consent We use necessary cookies to make our site function normally. With your consent, we’d also like to use analytics and marketing cookies. These help us improve the site’s performance and your experience of it. Adjust cookie settings Accept Decline You can change your cookie settings at any time. You are using an outdated browser. Please upgrade your browser to improve your experience. Open or close menu Home Help with your pain Osteoarthritic pain Sprains and strains RHEUMATOID ARTHRITIS Back pain Choose your Ibuleve Ibuleve Gel Maximum Strength Gel Pain Relief Gel Pain Relief Spray Max Strength Pain Relief Gel Where to buy Harnessing the painkilling anti-inflammatory power of ibuprofen. View The Range Max Strength Pain Relief Gel Pain Relief Spray Pain Relief Gel Ibuleve Gel Max Strength Gel There’s no stronger ibuprofen gel to fight pain. View the Product Clinically proven to work as fast and effectively as ibuprofen pills*. WATCH OUR AD All the benefits of Ibuleve |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 147 Content-Type: text/html; charset=UTF-8 Location: https://www.ibuleve.com/ Server: Microsoft-IIS/10.0 X-Powered-By: DDD Group Date: Mon, 28 Feb 2022 08:38:39 GMT HTTP/2 200 content-length: 41984 content-type: text/html; charset=utf-8 server: Microsoft-IIS/10.0 strict-transport-security: max-age=2592000 x-powered-by: DDD Group date: Mon, 28 Feb 2022 08:38:39 GMT |
ibuleve.com Whois Information
Domain Name: IBULEVE.COM Registry Domain ID: 41357534_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-11-06T05:11:54Z Creation Date: 2000-11-10T09:08:32Z Registry Expiry Date: 2022-11-10T09:08:32Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.NETNAMES.NET Name Server: NS2.NETNAMES.NET DNSSEC: unsigned >>> Last update of whois database: 2022-02-28T09:10:14Z <<< |